Clínica Baviera, S.A. (FRA:D9Z)

Clínica Baviera Statistics

Total Valuation

Clínica Baviera has a market cap or net worth of EUR 755.77 million. The enterprise value is 779.45 million.

Market Cap	755.77M
Enterprise Value	779.45M

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	Jun 11, 2025

Share Statistics

Current Share Class	16.01M
Shares Outstanding	n/a
Shares Change (YoY)	-0.15%
Shares Change (QoQ)	+1.70%
Owned by Insiders (%)	1.79%
Owned by Institutions (%)	3.90%
Float	2.18M

Valuation Ratios

The trailing PE ratio is 18.67.

PE Ratio	18.67
Forward PE	n/a
PS Ratio	2.55
PB Ratio	7.76
P/TBV Ratio	13.12
P/FCF Ratio	16.29
P/OCF Ratio	10.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.52, with an EV/FCF ratio of 16.80.

EV / Earnings	19.25
EV / Sales	2.63
EV / EBITDA	9.52
EV / EBIT	13.14
EV / FCF	16.80

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.68.

Current Ratio	0.98
Quick Ratio	0.98
Debt / Equity	0.68
Debt / EBITDA	0.81
Debt / FCF	1.44
Interest Coverage	20.98

Financial Efficiency

Return on equity (ROE) is 45.39% and return on invested capital (ROIC) is 23.87%.

Return on Equity (ROE)	45.39%
Return on Assets (ROA)	17.21%
Return on Invested Capital (ROIC)	23.87%
Return on Capital Employed (ROCE)	34.11%
Revenue Per Employee	203,960
Profits Per Employee	27,822
Employee Count	1,759
Asset Turnover	1.38
Inventory Turnover	n/a

Taxes

In the past 12 months, Clínica Baviera has paid 16.35 million in taxes.

Income Tax	16.35M
Effective Tax Rate	28.30%

Stock Price Statistics

The stock price has increased by +35.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+35.54%
50-Day Moving Average	41.94
200-Day Moving Average	40.15
Relative Strength Index (RSI)	63.99
Average Volume (20 Days)	48

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Clínica Baviera had revenue of EUR 296.76 million and earned 40.48 million in profits. Earnings per share was 2.53.

Revenue	296.76M
Gross Profit	138.78M
Operating Income	59.32M
Pretax Income	57.76M
Net Income	40.48M
EBITDA	81.87M
EBIT	59.32M
Earnings Per Share (EPS)	2.53

Balance Sheet

The company has 43.85 million in cash and 66.61 million in debt, giving a net cash position of -22.76 million.

Cash & Cash Equivalents	43.85M
Total Debt	66.61M
Net Cash	-22.76M
Net Cash Per Share	n/a
Equity (Book Value)	97.36M
Book Value Per Share	6.02
Working Capital	-1.33M

Cash Flow

In the last 12 months, operating cash flow was 72.09 million and capital expenditures -25.69 million, giving a free cash flow of 46.40 million.

Operating Cash Flow	72.09M
Capital Expenditures	-25.69M
Free Cash Flow	46.40M
FCF Per Share	n/a

Margins

Gross margin is 46.77%, with operating and profit margins of 19.99% and 13.64%.

Gross Margin	46.77%
Operating Margin	19.99%
Pretax Margin	19.46%
Profit Margin	13.64%
EBITDA Margin	27.59%
EBIT Margin	19.99%
FCF Margin	15.63%

Dividends & Yields

This stock pays an annual dividend of 1.27, which amounts to a dividend yield of 2.83%.

Dividend Per Share	1.27
Dividend Yield	2.83%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	63.13%
Buyback Yield	0.15%
Shareholder Yield	2.98%
Earnings Yield	5.36%
FCF Yield	6.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6